Clinical Nurse Specialist in Golden Valley, MN Accepting Medicare

2 Clinical Nurse Specialist nurses found. Showing 1 - 2

Eileen A Mckee, CNS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 5851 Duluth St, 115, Golden Valley, MN 55422 Phone: 763-543-6971    Fax: 763-543-6974

Ms. Sandra Faye Schleter, APRN BC CNS Clinical Nurse Specialist - Psych/Mental Health, Adult Medicare: Not Enrolled in Medicare Practice Location: 8085 Wayzata Blvd Suite 101, Bhsi Llc, Golden Valley, MN 55426 Phone: 651-769-6300    Fax: 651-769-6349

News Archive

Canadian conference on managing legal & business risks in clinical trials

The nature of clinical trials is constantly changing in the ever-more globalized and adapting market. In this increasingly-scrutinized industry, it is important to maintain a transparent process, to appropriately manage risks and to avoid abuses, in order to get a piece of this multi-billion dollar industry. How? By effectively managing the legal and business risks!

Cardioinsight completes long-term strategic financing to conclude multi-center clinical studies in Europe

CardioInsight Technologies, Inc., a leading developer of non-invasive electrocardiographic mapping technology, announced today that it has completed a long-term strategic financing that provides the Company with an initial investment of $15 million.

Researchers reveal neural responses associated with empathy for others' pain

Witnessing a person from our own group or an outsider suffer pain causes neural responses in two very different regions of the brain. And, the specific region activated reveals whether or not we will help the person in need. Researchers at the University of Zurich studied the brain responses of soccer fans and now have neurobiological evidence for why we are most willing to help members of our own group.

Ampio, Australian TGA reach agreement over Zertane submission plan

Ampio Pharmaceuticals, Inc., a company that discovers and develops new uses for previously approved drugs and new molecular entities, announced today that it reached agreement with the Therapeutic Goods Administration, Canberra, Australia, on a plan of drug manufacture and quality control for Zertane and the overall plan for the preparation of Common Technical Documents for the draft registration submission expected to be filed in June 2012.

Read more Medical News

› Verified 3 days ago